Dafiro

amlodipine; valsartan · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dafiro, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: EMA Authorised: Dafiro (amlodipine;valsartan) — Novartis Europharm Limited